Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020

Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020

Using a novel recruitment method and paired molecular and antibody testing for severe acute respiratory syndrome coronavirus 2 infection, we determined seroprevalence in a racially diverse municipality in Louisiana, USA. Infections were highly variable by ZIP code and differed by race/ethnicity. Ov...

Full description

Bibliographic Details
Main Authors: Amy K. Feehan, Daniel Fort, Julia Garcia-Diaz, Eboni G. Price-Haywood, Cruz Velasco, Eric Sapp, Dawn Pevey, Leonardo Seoane
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2020-11-01
Series:Emerging Infectious Diseases
Subjects:
COVID-19
coronavirus disease
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
viruses
respiratory infections
Online Access:https://wwwnc.cdc.gov/eid/article/26/11/20-3029_article
Description
Summary:Using a novel recruitment method and paired molecular and antibody testing for severe acute respiratory syndrome coronavirus 2 infection, we determined seroprevalence in a racially diverse municipality in Louisiana, USA. Infections were highly variable by ZIP code and differed by race/ethnicity. Overall census-weighted seroprevalence was 6.9%, and the calculated infection fatality ratio was 1.63%.
ISSN:1080-6040
1080-6059

Similar Items